SCHEMBL1932178

SCHEMBL1932178

Cc1ccc(NC(=O)C(CC2CCCC2)n2cnc(C(F)(F)F)cc2=O)nc1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1932175 1.00 GCK (0.73) GCK
SCHEMBL1930393 0.89 GCK (0.65) GCK
SCHEMBL1930387 0.89 GCK (0.65) GCK
SCHEMBL1739615 0.86 GCK (0.74) GCK
SCHEMBL1931232 0.86 GCK (0.68) GCK
SCHEMBL1931235 0.86 GCK (0.68) GCK
SCHEMBL3018145 0.86 GCK (0.74) GCK
SCHEMBL1930860 0.86 GCK (0.72) GCK
SCHEMBL1930863 0.86 GCK (0.72) GCK
SCHEMBL2197554 0.84 GCK (0.74) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110130365-A1 Fluorinated Heteroaryls BENBOW JOHN W 2011-06-02 US claimed
US-20110130365-A1 Fluorinated Heteroaryls BENBOW JOHN W 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130365-A1 Fluorinated Heteroaryls GCKR, GALK1, GCK GCK 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.